BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 5:17:00 PM | Browse: 1078 | Download: 931
Publication Name World Journal of Rheumatology
Manuscript ID 4328
Country Argentina
Received
2013-06-27 11:45
Peer-Review Started
2013-06-27 17:23
To Make the First Decision
2013-07-05 18:35
Return for Revision
2013-07-08 16:36
Revised
2013-08-30 21:58
Second Decision
2013-11-01 16:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-03 10:51
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-11-11 20:25
Publish the Manuscript Online
2013-11-19 16:17
ISSN 2220-3214 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Rheumatology
Manuscript Type Minireviews
Article Title Hot topics in lupus pregnancy
Manuscript Source Invited Manuscript
All Author List Javier A Cavallasca, Cecilia A Costa, Maria del Rosario Maliandi and Jorge L Musuruana
Funding Agency and Grant Number
Corresponding Author Javier A Cavallasca, MD, Sección Reumatología y Enfermedades Autoinmunes Sistémicas, Hospital JB Iturraspe, Bv. Pellegrini 3551, CP 3000, Santa Fe, Argentina. jcavallasca@yahoo.com.ar
Key Words Systemic lupus erythematosus; Pregnancy; Pre-eclampsia; Lupus nephritis; Neonatal lupus erythematosus; Congenital heart block
Core Tip Systemic lupus erythematosus (SLE) typically affects women in their childbearing age. The effect of pregnancy on the disease and the effect of SLE on pregnancy and the fetus are highly important issues for the attending physician. The newborn may be affected by the onset of neonatal lupus erythematosus, either as a skin or blood disease, or by the presence of congenital heart block. The frequent association between SLE and antiphospholipid syndrome represents another risk situation. Optimization of pharmacological therapy before and during pregnancy should be done in order to reduce adverse events to the mother and the baby.
Publish Date 2013-11-19 16:17
Citation Cavallasca JA, Costa CA, Maliandi MR, Musuruana JL. Hot topics in lupus pregnancy. World J Rheumatol 2013; 3(3): 32-39
URL http://www.wjgnet.com/2220-3214/full/v3/i3/32.htm
DOI http://dx.doi.org/10.5499/wjr.v3.i3.32
Full Article (PDF) WJR-3-32.pdf
Manuscript File 4328-Review.doc
Answering Reviewers 4328-Answering reviewers.pdf
Copyright License Agreement 4328-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 4328-Language certificate.pdf
Peer-review Report 4328-Peer review(s).pdf
Scientific Editor Work List 4328-Scientific editor work list.doc